SCHEMBL18177900

SCHEMBL18177900

CCOc1ccc(CN2CCN(c3ccccc3C)CC2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.61
DRD4 P21917 3/20 0.61
DRD3 P35462 2/20 0.61
ATM Q13315 1/20 0.56
POLB P06746 1/20 0.56
KDM4E B2RXH2 4/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
LMNA P02545 1/20 0.55
ALDH1A1 P00352 2/20 0.53
KMT2A Q03164 2/20 0.53
HTR1A P08908 1/20 0.53
HTR2B P41595 1/20 0.53
TP53 P04637 2/20 0.52
MEN1 O00255 1/20 0.52
NPC1 O15118 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
PKM P14618 1/20 0.52
MAPK1 P28482 1/20 0.52
FAAH O00519 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21164707 0.84 DRD4 (0.76) DRD2DRD4DRD3KDM4EALDH1A1
SCHEMBL6030752 0.83 LMNA (0.67) DRD2DRD4ATMPOLBKDM4E
SCHEMBL8131885 0.82 ATM (0.67) DRD2DRD4DRD3ATMPOLB
SCHEMBL6030972 0.81 ATM (0.62) DRD2DRD4DRD3ATMKDM4E
SCHEMBL18177896 0.80 ATM (0.64) DRD2DRD4ATMKDM4EALDH1A1
SCHEMBL11550567 0.80 ATM (0.61) DRD2DRD4DRD3ATMKDM4E
SCHEMBL18171326 0.80 MAPK1 (0.70) DRD2DRD4DRD3ATMKDM4E
SCHEMBL18181949 0.78 KDM4E (0.69) DRD2KDM4ESMN1; SMN2LMNAALDH1A1
SCHEMBL3436468 0.77 ATM (0.57) DRD2DRD4ATMKDM4ELMNA
SCHEMBL20157076 0.77 DRD2 (0.62) DRD2DRD4ATMKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200071735-A1 Compounds for Increasing Lipid Synthesis and Storage WASE, NISHIKANT 2020-03-05 US disclosed
US-10351883-B2 Compounds for increasing lipid synthesis and storage NUTECH VENTURES (US) 2019-07-16 US disclosed
US-20160312253-A1 Compounds for Increasing Lipid Synthesis and Storage INVITROGEN CORPORATION 2016-10-27 US disclosed
US-20160312253-A1 Compounds for Increasing Lipid Synthesis and Storage INVITROGEN CORPORATION 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160312253-A1 Compounds for Increasing Lipid Synthesis and Storage FASN, LIPC, SREBF2 DRD2 4274/4885DRD4 3838/4885DRD3 4217/4885
US-10351883-B2 Compounds for increasing lipid synthesis and storage FASN, LIPC, SREBF2 DRD2 4274/4885DRD4 3838/4885DRD3 4217/4885
US-20200071735-A1 Compounds for Increasing Lipid Synthesis and Storage FASN, LIPC, SREBF2 DRD2 4274/4885DRD4 3838/4885DRD3 4217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.